Skip to Content
Explore different treatments for your high cholesterol >

Pitavastatin Pregnancy and Breastfeeding Warnings

Pitavastatin is also known as: Livalo

Pitavastatin Pregnancy Warnings

Use in women who are or may become pregnant is contraindicated. US FDA pregnancy category: X Comments: -If the patient becomes pregnant while taking this drug, therapy should be discontinued and the patient should be apprised of the potential harm to the fetus. -Use of adequate methods of contraception should be encouraged.

Animal studies have revealed evidence of reduced body weight, abortion, decreased survival of neonates, and mortality at doses that also produced maternal toxicity. Rare cases of congenital anomalies following intrauterine exposure to HMG-CoA reductase inhibitors have been reported. There are no controlled data in human pregnancy. Serum cholesterol and triglycerides increase during normal pregnancy, and cholesterol products are essential for fetal development. Since atherosclerosis is a chronic process, discontinuation of lipid-lowering drugs during pregnancy should have little impact on long term outcomes of primary hyperlipidemia therapy. US FDA pregnancy category X: Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits.

See references

Pitavastatin Breastfeeding Warnings

Use is contraindicated. Excreted into human milk: Unknown Excreted into animal milk: Yes Comments: -A similar drug of this class has been detected in small amounts in human milk. -This drug should not be used during breastfeeding due to the potential for serious adverse events in nursing infants and the concern over disruption of infant lipid metabolism.

See references

References for pregnancy information

  1. "Product Information. Livalo (pitavastatin)." Kowa Pharmaceuticals America (formerly ProEthic), Montgomery, AL.

References for breastfeeding information

  1. "Product Information. Livalo (pitavastatin)." Kowa Pharmaceuticals America (formerly ProEthic), Montgomery, AL.
  2. United States National Library of Medicine "Toxnet. Toxicology Data Network. Available from: URL:" ([cited 2013 -]):

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.